In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Misonix buys Solsys Medical for $97mm plus net debt; acquisition closes at $109mm

11 Sep 2020

Executive Summary

Misonix Inc. penned a definitive agreement to acquire privately held regenerative medicine firm Solsys Medical LLC in an all-stock transaction. Misonix will issue approximately 5.7mm new shares valued at $97mm (based on the market average), and will also assume $20mm in outstanding secured debt.

Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Stock

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By